Biopharmaceutical Product Development from Research to Clinic
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Construction Starts on New Developmental Facility for Porton Biopharma
In a ceremony led by Baroness Scott of Bybrook OBE, Porton Biopharma (PBL) has begun construction of a new pharmaceutical development facility, which will provide state-of-the-art facilities...
Construction Starts on New Fermentation Facility at Porton Biopharma
In a ceremony led by Salisbury's MP John Glen, Porton Biopharma has initiated construction of a new multi-million...
Opening of the Pharm-Stores Extension Demonstrates Investment in Porton Biopharma
Chairman of the Porton Biopharma (PBL) Martin Hindle opened an extension of its facility for the storage of raw...
Next Steps for Porton Biopharma's Erwinase® Taken in Japan
Ohara Pharmaceutical have submitted a new drug application for PBL's Erwinase® in...
Minister for Life Sciences George Freeman Opens Porton Biopharma Manufacturing Facility
A new mutli-million pharmaceutical manufacturing facility has been opened at Porton Biopharma...
Public Health England to Transfer its Drug Development and Production to Porton Biopharma
The transfer of Public Health England's (PHE) clinical drug development and production capability into a standalone, state-owned biopharmaceutical limited company has been approved by the...